Zhili Tian

Coastal Carolina University - E. Craig Wall College of Business Administration

Conway, SC

United States

SCHOLARLY PAPERS

5

DOWNLOADS

319

SSRN CITATIONS

1

CROSSREF CITATIONS

1

Scholarly Papers (5)

1.

Buffer Location and Sizing to Optimize Cost and Quality in Semi-Continuous Manufacturing Processes: Methodology and Application

Number of pages: 41 Posted: 17 Jul 2006
Kumar Rajaram and Zhili Tian
University of California, Los Angeles - Anderson School of Business and Coastal Carolina University - E. Craig Wall College of Business Administration
Downloads 124 (309,174)
Citation 1

Abstract:

Loading...

buffer

2.

Dynamic Mergers Effects on R&D Investments and Drug Development Across Research Phases in the Pharmaceutical Industry

CESifo Working Paper No. 8303
Number of pages: 34 Posted: 20 May 2020
Ralph Siebert and Zhili Tian
Purdue University and Coastal Carolina University - E. Craig Wall College of Business Administration
Downloads 90 (383,120)

Abstract:

Loading...

drug development phases, dynamics, innovation management, merger and acquisition, pharmaceutical drug development, R&D capabilities

3.

Collaboration in Development of New Drugs

Number of pages: 42 Posted: 12 Dec 2019 Last Revised: 12 Jun 2020
Zhili Tian, Haresh Gurnani and Yi Xu
Coastal Carolina University - E. Craig Wall College of Business Administration, Wake Forest University School of Business and University of Maryland - Decision and Information Technologies Department
Downloads 69 (445,841)

Abstract:

Loading...

New Drug Development, New Drug Development Management, Clinical Trial, R&D Investment, Collaboration in Drug Development

4.

Dynamic Effects of Licensing and Knowledge Transfer Across Research Stages: Evidence from the Pharmaceutical Industry

CESifo Working Paper No. 8311
Number of pages: 41 Posted: 05 Jun 2020
Zhili Tian and Ralph Siebert
Coastal Carolina University - E. Craig Wall College of Business Administration and Purdue University
Downloads 36 (587,668)
Citation 1

Abstract:

Loading...

pharmaceutical drug development, licensing, R&D capabilities, effects of licensing on R&D capabilities

5.

Clinical Trials for New Drug Development: Optimal Investment and Application

Manufacturing & Service Operations Management, Forthcoming, Rotman School of Management Working Paper No. 2873859
Posted: 28 Nov 2016
Panos Kouvelis, Joseph Milner and Zhili Tian
Washington University in St. Louis, University of Toronto - Rotman School of Management and Coastal Carolina University - E. Craig Wall College of Business Administration

Abstract:

Loading...

Pharmaceutical Drug Development, Clinical Trial, R&D Project Management, Optimal Investment